We are live on ! Find out more

66 hedge funds and large institutions have $179M invested in CVRx in 2023 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 18 increasing their positions, 16 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

430% more call options, than puts

Call options by funds: $2.59M | Put options by funds: $489K

85% more capital invested

Capital invested by funds: $96.9M → $179M (+$82.1M)

30% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 20

13% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 16

10% more funds holding

Funds holding: 6066 (+6)

5.81% more ownership

Funds ownership: 50.18%55.98% (+5.8%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
66
Holders Change
+6
Holders Change %
+10%
% of All Funds
1.03%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
26
Increased
18
Reduced
16
Closed
20
Calls
$2.59M
Puts
$489K
Net Calls
+$2.1M
Net Calls Change
-$2.75M

CVRX Hedge Fund Activity: Q2 2023 in Review

66 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in CVRx (CVRX) for Q2 2023, worth a combined $179M — up 85% from $96.9M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new CVRX positions and 20 closed out — a net gain of 6 holders — while 18 added to existing stakes and 16 trimmed.

The largest buyer was BlackRock, adding an estimated $7.85M. The largest seller was Millennium Management, cutting an estimated $4.3M.

  • 66 institutional investors held CVRx (CVRX) as of Q2 2023, up from 60 in Q1 2023.
  • Funds reported $179M of CVRx stock for Q2 2023, up 85% quarter-over-quarter.
  • 26 funds opened new CVRx positions in Q2 2023 and 20 closed out, a net change of +6 holders.
  • The largest CVRx buyer in Q2 2023 was BlackRock, an estimated $7.85M added.
  • The largest CVRx seller in Q2 2023 was Millennium Management, an estimated $4.3M sold.

Based on aggregated 13F filings for Q2 2023.